Status:
COMPLETED
Saliva as Source of Detection for SARS-CoV-2
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Background: Nasopharyngeal (NP) swabbing is being used to test for SARS-CoV-2 infection. For this, a swab is inserted deep into the back of the nose to collect a sample. It can cause discomfort for m...
Detailed Description
Because of the inconvenience of nasopharyngeal (NP) testing for SARS-CoV-2 detection, we are interested in identifying different strategies for detecting infection. A technique that is less intrusive ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- To be eligible to participate in this study, an individual must meet all of the following criteria:
- Is one of the following:
- An NIH staff member participating in NIH CC SARS-CoV-2 surveillance, or
- A WHC patient who had or is having a diagnostic NP RT-PCR test for SARS-CoV-2.
- Age greater than or equal to 18 years.
- Able to provide informed consent.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Inability or unwillingness to have NP sampling or midturbinate sampling (applies to NIH site only).
- Inability or unwillingness to provide saliva sample (applies to both NIH and WHC sites).
Exclusion
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2020
Estimated Enrollment :
456 Patients enrolled
Trial Details
Trial ID
NCT04424446
Start Date
July 13 2020
End Date
September 4 2020
Last Update
June 2 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
2
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892